Topoisomerase I inhibition in BRCA+ and BRCA- ovarian cancer (OC): A single-institution experience.
D. M. Hyman
No relevant relationships to disclose
Q. Zhou
No relevant relationships to disclose
A. G. Arnold
No relevant relationships to disclose
R. N. Grisham
No relevant relationships to disclose
J. Bhatia
No relevant relationships to disclose
C. Aghajanian
No relevant relationships to disclose
A. Iasonos
No relevant relationships to disclose
D. R. Spriggs
No relevant relationships to disclose
N. D. Kauff
Consultant or Advisory Role - Pfizer
Expert Testimony - Pfizer